You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


Advertisement

ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | RSS | Access Rights | Sign In


  Vol. 117 No. 4, April 1982 TABLE OF CONTENTS
  Online Only
 •  Online First Table of
Contents
  ARTICLES
 •Online Features
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (19)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Delicious Add to Digg Add to Facebook Add to Reddit Add to Technorati Add to Twitter What's this?

Fatal Candida Esophagitis in Two Diabetics After Renal Transplantation

Jeffrey M. Jones, MD, PhD; Neal R. Glass, MD; Folkert O. Beizer, MD

Arch Surg. 1982;117(4):499-501.


Abstract



• Severe necrotizing Candida esophagitis developed in two insulin-dependent diabetics after they received renal allografts. In each patient, the infection led to a perforation of the esophagus and was ultimately fatal despite aggressive medical and surgical management. The frequency and severity of Candida esophagitis seems to be higher in diabetics rather than in nondiabetic patients who receive renal transplants. In these two diabetic transplant recipients, small doses of oral nystatin did not prevent Candida esophagitis. Appropriate diagnostic tests must be performed promptly when symptoms of odynophagia or dysphagia develop in these patients. In diabetic transplant recipients with documented candidiasis, decreased symptoms of esophagitis should not be relied on to indicate a response to therapy. Discontinuation of immunosuppressive drugs, as well as aggressive treatment with oral and parenterally absorbed antifungal agents, offer the best hope for preventing severe morbidity or mortality from the infection in these patients.

(Arch Surg 1982;117:499-501)



Author Affiliations



From the Infectious Disease Section, William S. Middleton Memorial Veterans Hospital, Madison, Wis (Dr Jones), and the Department of Medicine (Dr Jones) and the Renal Transplantation Service, Department of Surgery (Drs Glass and Belzer), University of Wisconsin School of Medicine, Madison.


Footnotes



Accepted for publication May 12, 1981.

Reprint requests to Infectious Disease Section, William S. Middleton Memorial Veterans Hospital, 2500 Overlook Terr, Madison, WI 53705 (Dr Jones).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Delicious Delicious   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Fatal Esophageal Perforation Caused by Invasive Candidiasis
Gock et al.
Ann. Thorac. Surg. 2005;80:1120-1122.
ABSTRACT | FULL TEXT  

Infectious necrotizing esophagitis: outcome after medical and surgical intervention
Gaissert et al.
Ann. Thorac. Surg. 2003;75:342-347.
ABSTRACT | FULL TEXT  

Surgical management of necrotizing Candida esophagitis
Gaissert et al.
Ann. Thorac. Surg. 1999;67:231-233.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | PHYSICIAN JOBS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1982 American Medical Association. All Rights Reserved.